These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 14755080)

  • 41. Protease site-restricted selection of phage-displayed peptides on glutathione-sepharose.
    Cui T; Jiang Y; Porter AG
    Anal Biochem; 1997 Jan; 244(1):186-7. PubMed ID: 9025931
    [No Abstract]   [Full Text] [Related]  

  • 42. The ribotoxic stress response as a potential mechanism for MAP kinase activation in xenobiotic toxicity.
    Laskin JD; Heck DE; Laskin DL
    Toxicol Sci; 2002 Oct; 69(2):289-91. PubMed ID: 12377976
    [No Abstract]   [Full Text] [Related]  

  • 43. Methods for the study of protein-protein interactions in cancer cell biology.
    Price D; Park I; Avraham H
    Methods Mol Biol; 2003; 218():255-67. PubMed ID: 12616725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MAP kinases.
    Chen Z; Gibson TB; Robinson F; Silvestro L; Pearson G; Xu B; Wright A; Vanderbilt C; Cobb MH
    Chem Rev; 2001 Aug; 101(8):2449-76. PubMed ID: 11749383
    [No Abstract]   [Full Text] [Related]  

  • 45. PlMAPK10, a Mitogen-Activated Protein Kinase (MAPK) in
    Jiang L; Situ J; Deng YZ; Wan L; Xu D; Chen Y; Xi P; Jiang Z
    Front Microbiol; 2018; 9():426. PubMed ID: 29568294
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Constitutive activity of JNK2 alpha2 is dependent on a unique mechanism of MAPK activation.
    Nitta RT; Chu AH; Wong AJ
    J Biol Chem; 2008 Dec; 283(50):34935-45. PubMed ID: 18940813
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stress-activated protein kinases-tumor suppressors or tumor initiators?
    Engelberg D
    Semin Cancer Biol; 2004 Aug; 14(4):271-82. PubMed ID: 15219620
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of Xenopus oocytes and early embryos to study MAPK signaling.
    Perdiguero E; Nebreda AR
    Methods Mol Biol; 2004; 250():299-314. PubMed ID: 14755096
    [No Abstract]   [Full Text] [Related]  

  • 49. Identification of MAPK substrates by expression screening with solid-phase phosphorylation.
    Fukunaga R; Hunter T
    Methods Mol Biol; 2004; 250():211-36. PubMed ID: 14755091
    [No Abstract]   [Full Text] [Related]  

  • 50. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
    Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R
    J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552
    [TBL] [Abstract][Full Text] [Related]  

  • 51. c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia.
    Waetzig V; Czeloth K; Hidding U; Mielke K; Kanzow M; Brecht S; Goetz M; Lucius R; Herdegen T; Hanisch UK
    Glia; 2005 May; 50(3):235-46. PubMed ID: 15739188
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of SAPKs/JNKs and p38s in vitro.
    Kyriakis JM; Liu H; Chadee DN
    Methods Mol Biol; 2004; 250():61-88. PubMed ID: 14755080
    [No Abstract]   [Full Text] [Related]  

  • 53. Dialogue between ERKs and JNKs: friendly or antagonistic?
    Dong Z; Bode AM
    Mol Interv; 2003 Sep; 3(6):306-8. PubMed ID: 14993462
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.